◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
iShares Genomics Immunology and Healthcare ETF (IDNA) ETF Overview
Price history, fund statistics and profile — an exchange-traded fund.
Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31
iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund managed by iShares in the "Health" category. It manages roughly $191 million in assets.
The fund generally will invest at least 80% of its assets in the component securities of the index and in investments that have economic characteristics that are substantially identical to the component securities of the index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents.
Interactive chart & fund stats →
IDNA Fund Statistics
| Expense ratio | 0.47% |
| Trailing yield | 0.87% |
| Assets under management | $191 million |
| Fund category | Health |
| Fund family | iShares |
| Inception | 2019-06-11 |
The live price chart, fund profile and news are in the interactive IDNA viewer.
Other Companies in Health
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.